Anika Therapeutics, Inc. (ANIK)
14.36
-0.04
(-0.24%)
USD |
NASDAQ |
Mar 04, 16:00
14.36
0.00 (0.00%)
After-Hours: 19:23
Anika Therapeutics Research and Development Expense (Annual) : 25.77M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 164.74M |
| Lantheus Holdings, Inc. | 177.31M |
| TELA Bio, Inc. | 8.813M |
| Plus Therapeutics, Inc. | 10.58M |
| BioStem Technologies, Inc. | 1.911M |